<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Ocugen, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Ocugen, Inc.

    Ocugen is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      3842
    • NIN CODE
      ####
    • LEADERSHIP
      Shankar Musunuri, PhD, MBA
    • FOUNDED
      2013
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Mereo BioPharma Group plc

    Mereo BioPharma Group plc

    Mereo BioPharma is a biopharmaceutical company focused on the development and comm...

    Mereo BioPharma is a biopharmaceutical company ...

    Filing Type:    PU
    I-PASS Patient Safety Institute, Inc.

    I-PASS Patient Safety Institute, Inc.

    We help save lives by improving verbal and written communications that occur betwe...

    We help save lives by improving verbal and writ...

    Amount Raised:    $149,055.00
    Fundraising Status:    EC
    Filing Type:    CF
    Centene Corporation

    Centene Corporation

    Centene Corporation, a Fortune 100 company, is a diversified, multi-national healt...

    Centene Corporation, a Fortune 100 company, is ...

    Filing Type:    PU
    Tricida, Inc.

    Tricida, Inc.

    Tricida, Inc. , Tricida, Inc. , is a pharmaceutical company focused on the develop...

    Tricida, Inc. , Tricida, Inc. , is a pharmaceut...

    Filing Type:    PU
    Novus Therapeutics, Inc.

    Novus Therapeutics, Inc.

    Novus Therapeutics, Inc. is a specialty pharmaceutical company focused on developi...

    Novus Therapeutics, Inc. is a specialty pharmac...

    Filing Type:    PU
    Immuron Limited

    Immuron Limited

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...

    Immuron Ltd is a publicly listed Australian bio...

    Filing Type:    PU
    Kala Pharmaceuticals, Inc.

    Kala Pharmaceuticals, Inc.

    Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the de...

    Kala Pharmaceuticals, Inc. (Kala) is a biopharm...

    Filing Type:    PU
    Clearside Biomedical, Inc.

    Clearside Biomedical, Inc.

    Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing ...

    Clearside Biomedical, Inc. is a biopharmaceutic...

    Filing Type:    PU
    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on ...

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a bi...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.